Prot# CERL080A US13: Sngl Ctr Plt Study for Trtmnt of Chronic Renal Allograft Rejection Using Asemtuzumab(Campath-1H)in Pts w/Prednisone-Free & Calcineurin-Inhibitor-Free Maintenance Immunosuppression Using Rapamycin+Mycophenolate Sodium (Myfort

Project: Research project

Project Details

StatusFinished
Effective start/end date5/1/056/15/10

Funding

  • Novartis Pharmaceuticals Corporation (CERL080A US13)